KIR3DL1 and cancer: Evidence for engagement of ligands upregulated on cancer cell lines independent of HLA expression [44], non-classical HLA molecules expressed by proliferating lymphoid and monocytic cells under inflammatory conditions [45, 46], and HLA-restricted viral epitopes [47], suggests that activating KIR signalling may be most productive in instances of cellular stress and infection.